journal article Mar 30, 2026

Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy

View at Publisher Save 10.7150/jca.131494
Topics

No keywords indexed for this article. Browse by subject →

Metrics
0
Citations
0
References
Details
Published
Mar 30, 2026
Vol/Issue
17(4)
Pages
819-834
Cite This Article
Kulsoom, Wajahat Ali, Zhe Ma, et al. (2026). Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy. Journal of Cancer, 17(4), 819-834. https://doi.org/10.7150/jca.131494